(Q38007362)

26 August 2017

CSF markers in amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

26 August 2017

0 references

author

Johannes Kornhuber

series ordinal

4

1 reference

26 August 2017

2

Alina Kułakowska

1 reference

26 August 2017

5

Piotr Lewczuk

1 reference

26 August 2017

1

Joanna Tarasiuk

1 reference

26 August 2017

Wiesław Drozdowski

3

1 reference

26 August 2017

4 May 2012

1 reference

Journal of Neural Transmission

26 August 2017

1 reference

26 August 2017

119

1 reference

26 August 2017

7

1 reference

26 August 2017

747-757

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-012-0806-y

26 August 2017

0 references

cites work

Progranulin in frontotemporal lobar degeneration and neuroinflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Serum and CSF immunological findings in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The blood-brain barrier: an overview: structure, regulation, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Pigment epithelium-derived factor (PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

ALS: a disease of motor neurons and their nonneuronal neighbors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Onset and progression in inherited ALS determined by motor neurons and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Raised nitrate concentration and low SOD activity in the CSF of sporadic ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Axonal damage markers in cerebrospinal fluid are increased in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Unraveling the mechanisms involved in motor neuron degeneration in ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Beta-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Oxidation versus aggregation - how do SOD1 mutants cause ALS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Neuroinflammation, COX-2, and ALS--a dual role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Cellular localization of gene expression for progranulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

No major progranulin genetic variability contribution to disease etiopathogenesis in an ALS Italian cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Low levels of the vascular endothelial growth factor in CSF from early ALS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The pharmacology and mechanism of action of riluzole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Implications of blood-brain barrier disruption in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Amyotrophic lateral sclerosis: a neurovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The prevalence of oligoclonal bands in the CSF of patients with primary neurodegenerative dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Pigment epithelium-derived factor is elevated in CSF of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Inflammatory processes in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Biochemistry and clinical role of human cystatin C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Glia cells in amyotrophic lateral sclerosis: new clues to understanding an old disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Elevated neurofilament levels in neurological diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Blood-brain barrier biology and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Molecular biology of amyotrophic lateral sclerosis: insights from genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Identification of potential CSF biomarkers in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Microglial upregulation of progranulin as a marker of motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The natural history of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Transglutaminase 2 in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The extracellular matrix of the central and peripheral nervous systems: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Genetics of sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Pathophysiology of blood-spinal cord barrier in traumatic injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Prognosis of amyotrophic lateral sclerosis with respiratory onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Amyotrophic lateral sclerosis: a review of current concepts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The pathobiology of amyotrophic lateral sclerosis: a proteinopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

CSF glial markers correlate with survival in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Preclinical and subclinical events in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Increased concentration of C4d complement protein in CSF in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Targeting the neurovascular unit for treatment of neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Assessment of disease progression in motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Bunina bodies in amyotrophic lateral sclerosis on Guam: a histochemical, immunohistochemical and ultrastructural investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Progranulin genetic variability contributes to amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Regulation of immune cell entry into the central nervous system

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

21 January 2018

12 December 2020

Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Decrease of S100 beta protein in serum of patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

Aquaporin-4 Overexpression in Rat ALS Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-012-0806-Y

The management of motor neurone disease.

21 January 2018

1 reference

12 December 2020

Metalloproteinase alterations in the bone marrow of ALS patients

1 reference

12 December 2020

Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients

1 reference

12 December 2020

Erratum: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

12 December 2020

Disruption of neurovascular unit prior to motor neuron degeneration in amyotrophic lateral sclerosis

1 reference

12 December 2020

Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models

1 reference

12 December 2020

Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.

1 reference

12 December 2020

Increased expression of laminin 1 in the skin of amyotrophic lateral sclerosis

1 reference

12 December 2020

Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view

1 reference

12 December 2020

Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Adenosine and neopterin levels in cerebrospinal fluid of patients with neurological disorders

1 reference

12 December 2020

Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors

1 reference

12 December 2020

Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis.

1 reference

12 December 2020

Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease

1 reference

12 December 2020

Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

S-100β protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

12 December 2020

Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases

1 reference

12 December 2020

Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration

1 reference

12 December 2020

The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis.

1 reference

12 December 2020

Genetics of amyotrophic lateral sclerosis

1 reference

12 December 2020

Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

1 reference

12 December 2020

Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue

1 reference

12 December 2020

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

1 reference

12 December 2020

Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study

1 reference

12 December 2020

Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system

1 reference

12 December 2020

Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosis

1 reference

12 December 2020

Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients

1 reference

12 December 2020

The pro and the active form of matrix metalloproteinase-9 is increased in serum of patients with amyotrophic lateral sclerosis

1 reference

12 December 2020

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

12 December 2020

10.1007/S00702-012-0806-Y

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22555610